Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04718168 · ClinicalTrials.gov registry record · NA
GORE® ENFORM Biomaterial Product Study
A NA study of Hernia, Ventral and Incisional Hernia, sponsored by W.L.Gore & Associates.
- Recruiting
- Registry status
- NA
- Development phase
- 245
- Enrollment target
- 9
- Study locations
NCT04718168 is a NA study of Hernia, Ventral and Incisional Hernia that is actively recruiting participants, run by W.L.Gore & Associates. The registered enrollment target is 245 participants, above the 148-participant average among 7 other Hernia, Ventral trials with a reported enrollment target (66% higher). The trial reports 9 study locations across 9 states.
The verdict
NCT04718168, a NA study of Hernia, Ventral and Incisional Hernia, is actively recruiting participants, sponsored by W.L.Gore & Associates.
- RECRUITING
- Registry status
- NA
- Development phase
- 245 participants
- Enrollment target
- 9
- Study locations
Study Summary
A prospective, retrospective, non-randomized, multicenter study with two independent hernia study cohorts (Ventral / Incisional Hernia Repair and Diaphragmatic / Hiatal Hernia Repair). The primary objective of this study is to collect GORE® ENFORM Biomaterial product commercial-use data on device functional performance and short-term patient experience.
Conditions Studied
Interventions
- DEVICE Gore ENFORM Biomaterial (Preperitoneal)
- DEVICE Gore ENFORM Biomaterial (Intraperitoneal)
Study Locations (9)
California
- University of California - San Diego - San Diego
Colorado
- Institute of Esophageal and Reflux Surgery - Denver
Florida
- Sarasota Memorial HealthCare System - Sarasota
Illinois
- Northshore University Health System Research Institute - Evanston
Kentucky
- University of Kentucky - Lexington
North Carolina
- Atrium Health - Charlotte
South Carolina
- Prisma Health - Upstate - Greenville
Texas
- University of Texas Health Science Center at Houson - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 245 participants |
| Start Date | 2021-05-17 |
| Est. Completion | 2026-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04718168
The ClinicalTrials.gov registry entry for NCT04718168 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 245 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 148-participant average among 7 other Hernia, Ventral trials with a reported enrollment target (66% higher). The listed sponsor is W.L.Gore & Associates, which has 53 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Hernia, Ventral appearing as the primary indexed condition, and to 2 interventions - of which Gore ENFORM Biomaterial (Preperitoneal) is the first listed.
NCT04718168 reports 9 study locations spanning 9 distinct geographic areas - top geographies include California, Colorado, Florida.
Frequently Asked Questions
What is clinical trial NCT04718168 about?
NCT04718168 is a clinical study titled "GORE® ENFORM Biomaterial Product Study". A prospective, retrospective, non-randomized, multicenter study with two independent hernia study cohorts (Ventral / Incisional Hernia Repair and Diaphragmatic / Hiatal Hernia Repair). The primary objective of this study is to collect GORE® ENFORM Biomaterial product commercial-use data on device fu...
What is the current status of trial NCT04718168?
This trial is currently recruiting. It is a NA study. The enrollment target is 245 participants. The study started on 2021-05-17. Estimated completion is 2026-09.
What conditions does trial NCT04718168 study?
This clinical trial studies the following conditions: Hernia, Ventral, Incisional Hernia, Hernia, Hiatal, Hernia, Diaphragmatic.
What interventions are being tested in trial NCT04718168?
The interventions under investigation include: Gore ENFORM Biomaterial (Preperitoneal) (DEVICE), Gore ENFORM Biomaterial (Intraperitoneal) (DEVICE).
Who is sponsoring clinical trial NCT04718168?
This trial is sponsored by W.L.Gore & Associates, which has 53 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04718168 being conducted?
This trial has 9 study locations across California, Colorado, Florida, Illinois, Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hernia, Ventral
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ventral or Inguinal Hernia, Robotically Repaired With OviTex Mesh
RECRUITING · NA
-
Transorb™ Self-Gripping Resorbable Mesh in High-risk Subjects Undergoing Open Repair of Ventral Hernia
ACTIVE NOT RECRUITING · NA
-
RCT of Two Noncrosslinked Porcine Acellular Dermal Matrices in Ab Wall Reconstruction
COMPLETED · NA
-
Laparoscopic Ventral Hernia Repair With Elastomeric Pain Pump
COMPLETED · NA
-
A Study to Understand the Utility of the Force Feedback Instruments in Robotic Procedures Using da Vinci 5 Robot
RECRUITING
-
Abdominal Wall Tension in Patients Undergoing Ventral Hernia Repair Without Component Separation
ACTIVE NOT RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.